BioCentury
ARTICLE | Company News

Bioniche Pharma Group Ltd., Nabi deal

April 23, 2007 7:00 AM UTC

NABI agreed to sell Aloprim IV allopurinol to Bioniche’s Bioniche Teoranta unit for $3.7 million. The move is part of NABI’s plan to reorganize into two business units and partner or sell certain of ...